Cited by 372Substance Abuse Treatment and OutcomesAlcohol Consumption and Health EffectsOpioid Use Disorder Treatment

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder

Reus, Victor I., Fochtmann, Laura J., Bukstein, Oscar, Eyler, A. Evan, Hilty, Donald M., Horvitz-Lennon, Marcela, Mahoney, Jane, Pasic, Jagoda, Weaver, Michael, Wills, Cheryl D., McIntyre, Jack, Kidd, Jeremy, Yager, Joel, Hong, Seung-Hee·2018·American Journal of Psychiatry

DOI 10.1176/appi.ajp.2017.1750101

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2017.1750101

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Clinical Practice Guidelines We Can Trust
Board on Health Care Services (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,146
Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III
Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0584 · Cited by 2,556
Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study: A Randomized Controlled Trial
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930
GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength
Andrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K. C., Meerpohl, J. J., Alonso‐Coello, P., Rind, D. M., Montori, V. M., Brito, J. P., Norris, S. L., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,366
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
Guyatt, G., Gutterman, D., Baumann, M. H., Addrizzo-Harris, D., Hylek, E. M., Phillips, B., Raskob, G., Lewis, S. Z., & Schünemann, H. (2006) · Chest · doi:10.1378/chest.129.1.174 · Cited by 1,220
Economic costs of excessive alcohol consumption in the U.S., 2006
Bouchery, E. E., Harwood, H. J., Sacks, J. J., Simon, C. J., & Brewer, R. D. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.06.045 · Cited by 1,041 · cited 1×
“According to a 2006 Centers for Disease Control and Prevention-sponsored study (Bouchery et al., 2011), AUD and its sequelae cost the U.S. $223.5 billion annually and account for significant excessmortality (Kendler etal., 2016).”
MethodInfluential
Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty
Mark, T. L., Kassed, C. A., Vandivort-Warren, R., Levit, K. R., & Kranzler, H. R. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.07.018 · Cited by 246
Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. Project MATCH Research Group.
(1998) · Journal of Studies on Alcohol · doi:10.15288/jsa.1998.59.631 · Cited by 205

Flagged first, then by citations

Show all 20 references

Sorted by citations

Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review
Kranzler, H. R., & Soyka, M. (2018) · JAMA · doi:10.1001/jama.2018.11406 · Cited by 580
Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association
Chung, M. K., Eckhardt, L. L., Chen, L. Y., Ahmed, H. M., Gopinathannair, R., Joglar, J. A., Noseworthy, P. A., Pack, Q. R., Sanders, P., & Trulock, K. M. (2020) · Circulation · doi:10.1161/cir.0000000000000748 · Cited by 565
Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis
Rogal, S. S., Youk, A. O., Zhang, H., Gellad, W. F., Fine, M. J., Good, C. B., Chartier, M., DiMartini, A. F., Morgan, T. R. M., Bataller, R. A., et al. (2019) · Hepatology · doi:10.1002/hep.31042 · Cited by 225
Hazardous drinking and alcohol use disorders
MacKillop, J. M., Agabio, R., Ewing, S. W. F., Heilig, M. A., Kelly, J. F., Leggio, L., Lingford-Hughes, A. R., Palmer, A. A., Parry, C. D. H., Ray, L. A., et al. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00406-1 · Cited by 251
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
Chuong, V., Farokhnia, M., Khom, S., Pince, C. L., Elvig, S. K., Vlkolinsky, R., Marchette, R. C. N., Koob, G. F., Roberto, M., Vendruscolo, L. F., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.170671 · Cited by 214
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease
Arab, J. P., Díaz, L. A., Rehm, J. T., Im, G. Y., Arrese, M. A., Kamath, P. S., Lucey, M. R., Mellinger, J. L., Thiele, M. S., Thursz, M. R., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.11.028 · Cited by 193
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Burnette, E. M., Nieto, S. J., Grodin, E. N., Meredith, L. R., Hurley, B., Miotto, K., Gillis, A. J., & Ray, L. A. (2022) · Drugs · doi:10.1007/s40265-021-01670-3 · Cited by 169
Mental health management of elite athletes during COVID-19: a narrative review and recommendations
Reardon, C. L., Bindra, A., Blauwet, C. A., Budgett, R., Campriani, N., Currie, A., Gouttebarge, V., Mcduff, D. R., Mountjoy, M. L., Purcell, R., et al. (2020) · British Journal of Sports Medicine · doi:10.1136/bjsports-2020-102884 · Cited by 161
Baclofen for the treatment of alcohol use disorder: the Cagliari Statement
Agabio, R., Sinclair, J., Addolorato, G., Aubin, H., Beraha, E. M., Caputo, F., Chick, J., Selle, P. D. L., Franchitto, N., Garbutt, J. C., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30303-1 · Cited by 137
Use of Medications for Alcohol Use Disorder in the US
Han, B., Jones, C. M., Einstein, E. B., Powell, P. A., & Compton, W. M. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.1271 · Cited by 135
Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation
Arab, J. P., Izzy, M. J., Leggio, L., Bataller, R. A., & Shah, V. H. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00527-0 · Cited by 129
Disulfiram: Mechanisms, Applications, and Challenges
Lanz, J., Biniaz-Harris, N., Kuvaldina, M., Jain, S., Lewis, K., & Fallon, B. A. (2023) · Antibiotics · doi:10.3390/antibiotics12030524 · Cited by 129
A meta-analysis of the efficacy of gabapentin for treating alcohol use disorder
Kranzler, H. R., Feinn, R., Morris, P., & Hartwell, E. E. (2019) · Addiction · doi:10.1111/add.14655 · Cited by 121
Controlled drinking—non‐abstinent versus abstinent treatment goals in alcohol use disorder: a systematic review, meta‐analysis and meta‐regression
Henssler, J. F., Müller, M., Carreira, H., Bschor, T., Heinz, A., & Baethge, C. (2020) · Addiction · doi:10.1111/add.15329 · Cited by 101
Scope, quality and inclusivity of international clinical guidelines on mental health and substance abuse in relation to dual diagnosis, social and community outcomes: a systematic review
Alsuhaibani, R., Smith, D. C., Lowrie, R., Aljhani, S., & Paudyal, V. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03188-0 · Cited by 116
Consistency between self-reported alcohol consumption and biological markers among patients with alcohol use disorder – A systematic review
Nielsen, D. G., Andersen, K., Nielsen, A. S., Juhl, C. B., & Mellentin, A. I. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.006 · Cited by 84
Stigmatization of people with addiction by health professionals: Current knowledge. A scoping review
Cazalis, A., Lambert, L., & Auriacombe, M. (2023) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2023.100196 · Cited by 92
Academy of Breastfeeding Medicine Clinical Protocol #21: Breastfeeding in the Setting of Substance Use and Substance Use Disorder (Revised 2023)
Harris, M. T. H., Schiff, D. M., Saia, K., Muftu, S., Standish, K. R., & Wachman, E. M. (2023) · Breastfeeding Medicine · doi:10.1089/bfm.2023.29256.abm · Cited by 108
Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis
Rabiee, A., Mahmud, N., Falker, C. G., García–Tsao, G., Taddei, T. H., & Kaplan, D. E. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000093 · Cited by 78
The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective
de Beaurepaire, R., Sinclair, J. M. A., Heydtmann, M., Addolorato, G., Aubin, H.-J., Beraha, E. M., Caputo, F., Chick, J. D., de La Selle, P., Franchitto, N., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00708 · Cited by 95
Technology‐Delivered Cognitive‐Behavioral Interventions for Alcohol Use: A Meta‐Analysis
Kiluk, B. D., Ray, L. A., Walthers, J., Bernstein, M. H., Tonigan, J. S., & Magill, M. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14189 · Cited by 84
Evidence-Based Pharmacotherapies for Alcohol Use Disorder
Fairbanks, J., Umbreit, A., Kolla, B. P., Karpyak, V. M., Schneekloth, T. D., Loukianova, L. L., & Sinha, S. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.01.030 · Cited by 75
Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis
Bahji, A., Bach, P., Danilewitz, M., Crockford, D. N., Devoe, D. J. A., el‐Guebaly, N., & Saitz, R. (2022) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000992 · Cited by 80
Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use Disorder
Arab, J. P., Addolorato, G., Mathurin, P., & Thursz, M. R. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.02.017 · Cited by 71
Integrating Treatment for Co-Occurring Mental Health Conditions
Yule, A. (2019) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v40.1.07 · Cited by 63
Evidence-Based Treatment of Young Adults With Substance Use Disorders
Hadland, S. E., Yule, A. M., Levy, S., Hallett, E., Silverstein, M., & Bagley, S. M. (2021) · PEDIATRICS · doi:10.1542/peds.2020-023523d · Cited by 70
Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
Staufer, K., & Stauber, R. E. (2023) · Biomedicines · doi:10.3390/biomedicines11082108 · Cited by 63
Anticraving therapy for alcohol use disorder: A clinical review
Shen, W. W. (2018) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12028 · Cited by 61
Diagnosis and Treatment of Alcohol Use Disorder in Patients With End‐Stage Alcoholic Liver Disease
Caputo, F., Domenicali, M., & Bernardi, M. (2018) · Hepatology · doi:10.1002/hep.30358 · Cited by 57
Pharmacological Management of Borderline Personality Disorder and Common Comorbidities
Pascual, J. C., Arias, L., & Soler, J. (2023) · CNS Drugs · doi:10.1007/s40263-023-01015-6 · Cited by 61
Diagnosis and treatment of acute alcohol intoxication and alcohol withdrawal syndrome: position paper of the Italian Society on Alcohol
Caputo, F., Agabio, R., Vignoli, T., Patussi, V., Fanucchi, T., Cimarosti, P., Meneguzzi, C., Greco, G., Rossin, R., Parisi, M., et al. (2018) · Internal and Emergency Medicine · doi:10.1007/s11739-018-1933-8 · Cited by 54
WFSBP and IAWMH Guidelines for the treatment of alcohol use disorders in pregnant women
Thibaut, F., Chagraoui, A., Buckley, L., Gressier, F., Labad, J., Lamy, S., Potenza, M. N., Kornstein, S. G., Rondón, M. B., Riecher‐Rössler, A., et al. (2019) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1510185 · Cited by 59
Outcomes After Initiation of Medications for Alcohol Use Disorder at Hospital Discharge
Bernstein, E. Y., Baggett, T. P., Trivedi, S., Herzig, S. J., & Anderson, T. S. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.3387 · Cited by 53
Baclofen for alcohol use disorder
Agabio, R., Saulle, R., Rösner, S., & Minozzi, S. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012557.pub3 · Cited by 54
Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
Shirley, D.-A. T., Sharma, I., Warren, C. A., & Moonah, S. N. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.633194 · Cited by 48
Alcohol use disorder in community management of chronic liver diseases
Leggio, L., & Mellinger, J. L. (2022) · Hepatology · doi:10.1002/hep.32531 · Cited by 51
Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective
Díaz, L. A., König, D., Weber, S., Ayares, G., Fuentealba, J. M., Vázquez, V., Bataller, R. A., Kamath, P. S., Winder, G. S., Leggio, L., et al. (2025) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00380-7 · Cited by 51
The future of translational research on alcohol use disorder
Ray, L. A., Grodin, E. N., Leggio, L., Bechtholt, A. J., Becker, H. C., Ewing, S. W. F., Jentsch, D., King, A. C., Mason, B. J., O’Malley, S. S., et al. (2020) · Addiction Biology · doi:10.1111/adb.12903 · Cited by 51
Practical outpatient pharmacotherapy for alcohol use disorder
Kim, Y., Hack, L. M., Ahn, E. S., & Kim, J. (2018) · Drugs in Context · doi:10.7573/dic.212308 · Cited by 47
Understanding the neurobiological effects of drug abuse: Lessons from zebrafish models
Müller, T. E., Fontana, B. D., Bertoncello, K. T., Franscescon, F., Mezzomo, N. J., Canzian, J., Stefanello, F. V., Parker, M. O., Gerlai, R. T., & Rosemberg, D. B. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109873 · Cited by 51
New insights into the molecular basis of alcohol abstinence and relapse in alcohol-associated liver disease
Díaz, L. A., Winder, G. S., Leggio, L., Bajaj, J. S., Bataller, R. A., & Arab, J. P. (2023) · Hepatology · doi:10.1097/hep.0000000000000645 · Cited by 47
Alcohol Use
Donroe, J. H., & Edelman, E. J. (2022) · Annals of Internal Medicine · doi:10.7326/aitc202210180 · Cited by 44
Medications for treating alcohol use disorder: A narrative review
Kranzler, H. R., & Hartwell, E. E. (2023) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15118 · Cited by 50
The Effect of High-Frequency Repetitive Transcranial Magnetic Stimulation on Emotion Processing, Reappraisal, and Craving in Alcohol Use Disorder Patients and Healthy Controls: A Functional Magnetic Resonance Imaging Study
Jansen, J. M., van den Heuvel, O. A., van der Werf, Y. D., de Wit, S. J., Veltman, D. J., van den Brink, W., & Goudriaan, A. E. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00272 · Cited by 43
Advances in the understanding and management of alcohol-related liver disease
Thursz, M. R., & Lingford-Hughes, A. R. (2023) · BMJ · doi:10.1136/bmj-2023-077090 · Cited by 41
Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE‐4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department
Borgundvaag, B., Bellolio, F., Miles, I., Schwarz, E. S., Sharif, S., Su, M. K., Baumgartner, K. T., Liss, D. B., Sheikh, H., Vogel, J. A., et al. (2024) · Academic Emergency Medicine · doi:10.1111/acem.14911 · Cited by 42
Prevalence of and pathways to benzodiazepine use in Brazil: the role of depression, sleep, and sedentary lifestyle
Madruga, C. S., Paim, T. L., Alves, H. N. P., Miguel, A. C., Massaro, L. T. S., Caetano, R., & Laranjeira, R. (2018) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2018-0088 · Cited by 40
Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: Results from a systematic review and meta-analysis
Gratacós‐Ginès, J., Bruguera, P., Pérez-Guasch, M., López-Lazcano, A., Borràs, R., Hernández-Évole, H., Pons-Cabrera, M. T., Lligoña, A., Bataller, R. A., Ginès, P., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000570 · Cited by 39
Alcohol-Associated Liver Disease: Evolving Concepts and Treatments
Prince, D. S., Nash, E., & Liu, K. (2023) · Drugs · doi:10.1007/s40265-023-01939-9 · Cited by 40
The Spectrum of Alcohol Use
Cohen, S. M., Alexander, R. S., & Holt, S. R. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.08.003 · Cited by 39
Metabolic dysfunction and alcohol-associated liver disease (MetALD)
Gao, B., Arab, J. P., Liangpunsakul, S., Ding, W., Szabó, G., Mehal, W. Z., Wang, H., He, Y., Stärkel, P., Llorente, C., et al. (2025) · eGastroenterology · doi:10.1136/egastro-2025-100319 · Cited by 43
Pharmacological GHSR (ghrelin receptor) blockade reduces alcohol binge-like drinking in male and female mice
Richardson, R. S., Sulima, A., Rice, K. C., Kucharczk, J. A., Janda, K. D., Nisbett, K. E., Koob, G. F., Vendruscolo, L. F., & Leggio, L. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109643 · Cited by 35
The use of person-centered language in scientific research articles focusing on alcohol use disorder
Hartwell, M. L., Naberhaus, B., Arnhart, C., Ottwell, R., Dunn, K. E., Rogers, T., Vassar, M. B., & Beaman, J. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108209 · Cited by 33
Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years
Blanco-Gandía, M. C., & Rodríguez‐Arias, M. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.007 · Cited by 35
Correlates of alcohol use disorder pharmacotherapy receipt in medically insured patients
Rittenberg, A., Hines, A. L., Alvanzo, A. A. H., & Chander, G. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108174 · Cited by 32
Pharmacologic Treatment Initiation Among Medicare Beneficiaries Hospitalized With Alcohol Use Disorder
Bernstein, E. Y., Baggett, T. P., Trivedi, S., Herzig, S. J., & Anderson, T. S. (2023) · Annals of Internal Medicine · doi:10.7326/m23-0641 · Cited by 32
Impact of a pharmacist-led substance use disorder transitions of care clinic on postdischarge medication treatment retention
Smith, A. T., Hansen, J., & Colvard, M. D. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108440 · Cited by 30
Survey of Addiction Specialists’ Use of Medications to Treat Alcohol Use Disorder
Ehrie, J., Hartwell, E. E., Morris, P. E., Mark, T. L., & Kranzler, H. R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00047 · Cited by 29
Pharmacotherapy for alcohol use disorders – Unequal provision across sociodemographic factors and co-morbid conditions. A cohort study of the total population in Sweden
Finn, S. W., Lundin, A., Sjöqvist, H., & Danielsson, A. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108964 · Cited by 28
Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse
Daniel, J., Dumortier, J., Bello, A. D., Gamon, L., Molinari, N., Faure, S., Meszaros, M., Bedoya, J. U., Meunier, L., Monet, C., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100832 · Cited by 28
Alcohol use disorder in alcohol-associated liver disease: Two sides of the same coin
Singal, A. K., Leggio, L., & DiMartini, A. F. (2023) · Liver Transplantation · doi:10.1097/lvt.0000000000000296 · Cited by 28
Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV
Oldfield, B. J., McGinnis, K. A., Edelman, E. J., Williams, E. C., Gordon, A. J., Akgün, K. M., Crystal, S., Fiellin, L. E., Gaither, J. R., Goulet, J. L., et al. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.11.002 · Cited by 26
Implementation of Oral and Extended-Release Naltrexone for the Treatment of Emergency Department Patients With Moderate to Severe Alcohol Use Disorder: Feasibility and Initial Outcomes
Anderson, E. S., Chamberlin, M., Zuluaga, M., Ullal, M., Hawk, K. F., McCormack, R. P., D’Onofrio, G., & Herring, A. A. (2021) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2021.05.013 · Cited by 26
Review article: current and emerging therapies for acute alcohol‐associated hepatitis
Rattan, P., & Shah, V. H. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16969 · Cited by 28
Astrocytic GABAergic Regulation in Alcohol Use and Major Depressive Disorders
Ali, D. N., Ali, H. M., Lopez, M. R., Kang, S., & Choi, D. (2024) · Cells · doi:10.3390/cells13040318 · Cited by 26
Alcohol Use Disorder in Older Adults
Fenollal-Maldonado, G., Brown, D. S., Hoffman, H. L., Kahlon, C. K., & Grossberg, G. T. (2021) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2021.07.006 · Cited by 26
Revised Clinical Practice Guidelines of the Korean Pancreatobiliary Association for Acute Pancreatitis
Lee, S. H., Choe, J. W., Cheon, Y. K., Choi, M., Jung, M. K., Jang, D. K., Jo, J. H., Lee, J. M., Kim, E. J., Han, S. Y., et al. (2022) · Gut and Liver · doi:10.5009/gnl220108 · Cited by 25
Baclofen in the Treatment of Patients With Alcohol Use Disorder and Other Mental Health Disorders
Agabio, R., & Leggio, L. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00464 · Cited by 25
A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder
Celik, M., Gold, M. S., & Fuehrlein, B. (2024) · Brain Sciences · doi:10.3390/brainsci14030294 · Cited by 25
Ayahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity
Gianfratti, B., Tabach, R., Sakalem, M. E., Stessuk, T., Maia, L. O., & Carlini, E. A. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114865 · Cited by 25
Inpatient adoption of medications for alcohol use disorder: A mixed-methods formative evaluation involving key stakeholders
Joudrey, P. J., Oldfield, B. J., Yonkers, K. A., O’Connor, P. G., Berland, G. K., & Edelman, E. J. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108090 · Cited by 23
Treatment of alcohol use disorder in patients with liver disease
Nielsen, A. S., Askgaard, G., & Thiele, M. S. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.11.012 · Cited by 23
Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective?
Antonelli, M., Sestito, L., Tarli, C., & Addolorato, G. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.05.016 · Cited by 23
Pharmacotherapeutic options for co-morbid depression and alcohol dependence
Hillemacher, T., & Frieling, H. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1561870 · Cited by 24
Efficacy of medications for the treatment of alcohol use disorder (AUD): A systematic review and meta-analysis considering baseline AUD severity
Agabio, R., López‐Pelayo, H., Bruguera, P., Huang, S., Sardo, S., Peciña, M., Krupitsky, E. M., Fitzmaurice, G. M., & Lin, Z. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107454 · Cited by 24
Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider?
Kelty, E. A., Terplan, M., Greenland, M., & Preen, D. B. (2021) · Drugs · doi:10.1007/s40265-021-01509-x · Cited by 25
Effect of vortioxetine in subjects with major depressive and alcohol use disorders: a 6-month retrospective analysis
Nicola, M. D., Pepe, M., Panaccione, I., Moccia, L., Dattoli, L., Molinaro, M., Sani, G., Janiri, L., & McIntyre, R. S. (2020) · CNS Spectrums · doi:10.1017/s109285292000173x · Cited by 22
Association of Syndemic Unhealthy Alcohol Use, Smoking, and Depressive Symptoms on Incident Cardiovascular Disease among Veterans With and Without HIV-Infection
Chichetto, N. E., Kundu, S., Freiberg, M. S., Koethe, J. R., Butt, A. A., Crystal, S., So-Armah, K. A., Cook, R. L., Braithwaite, R. S., Justice, A. C., et al. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03327-4 · Cited by 20
What can primary care services do to help First Nations people with unhealthy alcohol use? A systematic review: Australia, New Zealand, USA and Canada
Purcell‐Khodr, G., Lee, K. S., Conigrave, J. H., Webster, E., & Conigrave, K. M. (2020) · Addiction Science & Clinical Practice · doi:10.1186/s13722-020-00204-8 · Cited by 21
Mifepristone decreases chronic voluntary ethanol consumption in Rhesus macaques
Jimenez, V. A., Walter, N. A. R., Shnitko, T. A., Newman, N., Diem, K., Vanderhooft, L., Hunt, H., & Grant, K. A. (2020) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000169 · Cited by 20
Addiction Consult Service and Inpatient Outcomes Among Patients with Alcohol Use Disorder
Singh‐Tan, S., Torres‐Lockhart, K., Jakubowski, A. U., Lu, T. Y., Starrels, J. L., Lima, P. D., Arnsten, J. H., Nahvi, S., & Southern, W. N. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08202-7 · Cited by 21
Imaginal retraining reduces alcohol craving in problem drinkers: A randomized controlled trial
Moritz, S., Paulus, A. M., Hottenrott, B., Weierstall, R., Gallinat, J., & Kühn, S. (2019) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2019.04.001 · Cited by 20
Integration of A Clinical Pharmacy Specialist into A Substance Use Disorder Intensive Outpatient Treatment Program to Improve Prescribing Rates of Alcohol Use Disorder Pharmacotherapy
Dimitropoulos, E., Bertucci, S., & Wong, K. R. (2018) · Substance Abuse · doi:10.1080/08897077.2018.1449172 · Cited by 20
Naltrexone Initiation in the Inpatient Setting for Alcohol Use Disorder: A Systematic Review of Clinical Outcomes
Kirchoff, R. W., Mohammed, N. M., McHugh, J., Markota, M., Kingsley, T. C., Leung, J. G., Burton, M., & Chaudhary, R. (2021) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2021.01.013 · Cited by 19
Alcohol use disorders
Rehm, J. T., Assanangkornchai, S., Hendershot, C. S., Franklin, A., Neufeld, M., Hassan, A. S., & Shield, K. D. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01496-5 · Cited by 25
Which interventions for alcohol use should be included in a universal healthcare benefit package? An umbrella review of targeted interventions to address harmful drinking and dependence
Botwright, S., Sutawong, J., Kingkaew, P., Anothaisintawee, T., Dabak, S. V., Suwanpanich, C., Promchit, N., Kampang, R., & Isaranuwatchai, W. (2023) · BMC Public Health · doi:10.1186/s12889-023-15152-6 · Cited by 21
Characterizing the Variation of Alcohol Cessation Pharmacotherapy in Primary Care
Bernstein, E. Y., Guo, N., Goto, T., & Rothberg, M. B. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06454-1 · Cited by 19
Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities
Qeadan, F., Mensah, N. A., Gu, L. Y., Madden, E. F., Venner, K. L., & English, K. C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168884 · Cited by 17
Medication prescribing for alcohol use disorders during alcohol‐related encounters in a Colorado regional healthcare system
Chockalingam, L., Burnham, E. L., & Jolley, S. E. (2022) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14837 · Cited by 17
The impact of COVID‐19 on trends in alcohol use disorder treatment in Veterans Health Administration
Perumalswami, P., Kilpatrick, S., Frost, M. C., Adams, M. A., Kim, H. M., Zhang, L., & Lin, L. A. (2023) · Addiction · doi:10.1111/add.16156 · Cited by 17
Integrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder
Haque, L., & Leggio, L. (2024) · Hepatology · doi:10.1097/hep.0000000000000996 · Cited by 19
Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder
Ellis, M. S., Xu, K. Y., Tardelli, V. S., Fidalgo, T. M., Buttram, M. E., & Grucza, R. A. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.3145 · Cited by 16
Medication Utilization for Alcohol Use Disorder in a Commercially Insured Population
Huskamp, H. A., Reif, S., Greenfield, S. F., Normand, S. T., & Busch, A. B. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06073-w · Cited by 16
A cohort study examining changes in treatment patterns for alcohol use disorder among commercially insured adults in the United States during the COVID-19 pandemic
Busch, A. B., Mehrotra, A., Greenfield, S. F., Uscher‐Pines, L., Rose, S., & Huskamp, H. A. (2022) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2022.108920 · Cited by 16
Cascade of Hepatitis C Virus Care Among Patients With Substance Use Disorders
Jiang, X., Parker, R. L., Vouri, S. M., Lo‐Ciganic, W., Diaby, V., Henry, L. L., & Park, H. (2021) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.04.013 · Cited by 15
Integrative Pharmacology in the Treatment of Substance Use Disorders
Donlon, J., Kumari, P., Varghese, S. P., Bai, M. Y., Florentin, O. D., Frost, E. D., Banks, J., Vadlapatla, N., Kam, O., Shad, M. U., et al. (2023) · Journal of Dual Diagnosis · doi:10.1080/15504263.2023.2293854 · Cited by 15
Barriers and Facilitators to Changing Drinking and Receiving Alcohol-Related Care: Interviews with Veterans Health Administration Primary Care Patients who Indicated Interest but Did Not Enroll in An Alcohol Care Management Intervention Trial
Frost, M. C., Matson, T. E., Richards, J. A., Lee, A. K., Achtmeyer, C. E., Bradley, K. A., & Williams, E. C. (2022) · Substance Abuse · doi:10.1080/08897077.2022.2074602 · Cited by 15
Cross-species alcohol dependence-associated gene networks: Co-analysis of mouse brain gene expression and human genome-wide association data
Mignogna, K. M., Bacanu, S., Riley, B. P., Wolen, A. R., & Miles, M. F. (2019) · PLoS ONE · doi:10.1371/journal.pone.0202063 · Cited by 15
Neurobiology and the Treatment of Alcohol Use Disorder: A Review of the Evidence Base
Donato, S., & Ray, L. A. (2023) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s409943 · Cited by 17
Long‐term safety and efficacy of nalmefene in Japanese patients with alcohol dependence
Higuchi, S., Takahashi, M., Murai, Y., Tsuneyoshi, K., Nakamura, I., Meulien, D., & Miyata, H. (2020) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13017 · Cited by 14

Authors: Reus, V. I., Fochtmann, L. J., Bukstein, O., Eyler, A. E., Hilty, D. M., Horvitz-Lennon, M., Mahoney, J., Pasic, J., Weaver, M., Wills, C. D., McIntyre, J., Kidd, J., Yager, J., & Hong, S.-H.
Affiliations: From the APA Practice Guideline Writing Group (Victor I. Reus, M.D., Chair)
ORCID: Reus, Victor I.
Fochtmann, Laura J.
Hilty, Donald M.
Horvitz-Lennon, Marcela
Weaver, Michael
Kidd, Jeremy
Yager, Joel
Venue: American Journal of Psychiatry
Publisher: American Psychiatric Association Publishing
Published: 2018-01-01
Volume: 175
Issue: 1
Pages: 86-90
ISSN: 0002-953X (ISSN-L)
1535-7228
DOI: 10.1176/appi.ajp.2017.1750101
OpenAlex: W2782206210
Cited by: 372
References: 20
Citations by year: 2026: 40 · 2025: 50 · 2024: 57 · 2023: 70 · 2022: 41 · 2021: 37 · 2020: 28 · 2019: 27 · 2018: 17
FWCI: 21.28
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords: alcoholism, pharmacotherapy, treatment guidelines
MeSH terms: Alcoholism, Humans, Patient Care Management, Psychological Techniques, Psychotropic Drugs, United States, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks